Illustration of blue cells
Keck School of Medicine of USC

USC/CHLA Cell Therapy Program

Are you a Patient?

Our vision is to become a world-leading hub contributing to the rapidly growing field of cell therapy and to provide novel life-saving treatments to our patients, especially those suffering from health care disparities.

Mohamed Abou-el-Enein Executive Director, USC/CHLA Cell Therapy Program
Mohamed Abou-el-Enein Executive Director, USC/CHLA Cell Therapy Program

About the Program

Combined logo of CHLA and USC
The USC/CHLA Cell Therapy Program, established in 2021, aims to facilitate the translation of cutting-edge cell and gene therapy research into clinical applications by providing comprehensive support, state-of-the-art facilities, and alignment with regulatory standards. As part of the CIRM alpha clinics network, it offers researchers and collaborators a holistic partnership, encompassing strategic planning, manufacturing, quality control, and collaborative opportunities to advance novel therapies within a robust translational ecosystem.

Read more about the Cell Therapy Program
Staff transport cell samples
Gears illustration

Services

One-stop solutions to advance projects from preclinical development to all phases of clinical trials. Capabilities include product manufacturing, quality control, regulatory services and more.

Microscopic section of kidney tissue

Research

Areas of focus include enabling novel technologies under GMP conditions, optimizing manufacturing and product development workflows as well as scaling up/out processes.

Cell Therapy staff teahing

Training & Education

CTP offers course instruction on the process of drug development and translating basic science research discoveries into clinical applications specifically in the field of cell and gene therapies.